Testing an Integrated Care Model Trial
This study aims to test the use of an adapted collaborative care model for improving the health outcomes of adults diagnosed with type 1 diabetes (T1D). The duration of the study is 18 months with 4 study survey points. Participants will fill out an online survey regarding their psychosocial health and chronic disease management behaviors once every six months over the 18 months, and individuals who are randomly assigned to the study intervention will also consult at least once with a behavioral health consultant during the first year (active intervention period).
Conditions:
🦠 Diabetes Mellitus, Type 1
🗓️ Study Start (Actual) 10 June 2024
🗓️ Primary Completion (Estimated) January 2026
✅ Study Completion (Estimated) January 2026
👥 Enrollment (Estimated) 80
🔬 Study Type INTERVENTIONAL
📊 Phase NA
Locations:
📍 Atlanta, Georgia, United States

📋 Eligibility Criteria

Description

    Inclusion Criteria:

    • * Adults (≥18 years) with T1D (based on clinical record diagnosis).

    Exclusion Criteria:

    • * Patients who do not speak English or have reliable telephone access will be excluded. ---
    • * Individuals with the presence of severe psychiatric illness (PHQ-9≥20) or active suicidal ideation will also be excluded and referred to specialty care.
Ages Eligible for Study: 18 Years to N/A (ADULT, OLDER_ADULT)
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: Yes

🗓️ Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

  • First Submitted 4 June 2024
  • First Submitted that Met QC Criteria 4 June 2024
  • First Posted 7 June 2024

Study Record Updates

  • Last Update Submitted that Met QC Criteria 24 June 2024
  • Last Update Posted 25 June 2024
  • Last Verified June 2024